Top

Published in:

01-06-2014 | Case Report

Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient: report of a rare case

Authors: E. Jin, L. M. Wang, Q. Y. Li, X. Feng, S. L. Ma

Published in: Infection | Issue 3/2014

Abstract

Chronic necrotizing pulmonary aspergillosis (CNPA) is a relatively uncommon manifestation of infection with Aspergillus spp. which mainly affects immunocompromised or immunostressed individuals with underlying lung diseases. Here, we present a case of mediastinum-involved CNPA in an immunocompetent patient with no symptoms and previous good health.

Parra I, Remacha A, Rezusta A, et al. Chronic necrotizing pulmonary aspergillosis. Med Mycol. 2004;42:369–71.PubMedCrossRef

Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13.PubMedCrossRef

Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2011;37:865–72.PubMedCrossRef

Franquet T, Müller NL, Giménez A, Domingo P, Plaza V, Bordes R. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. Am J Roentgenol. 2000;174:51–6.CrossRef

Shakoor MT, Ayub S, Ayub Z, Mahmood F. Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report. J Med Case Rep. 2012;6:311.PubMedCentralPubMedCrossRef

Sridhar V, Rajagopalan N, Shivaprasad C, Patil M, Varghese J. Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host. BMJ Case Rep. 2012;. doi:10.1136/bcr.09.2011.4866 (pii): bcr0920114866.

Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs. 2007;67:1567–601.PubMedCrossRef

Jung SW, Kim MW, Cho SK, Kim HU, Lee DC, Yoon BK, Jeong JP, Ko YC. A case of endobronchial aspergilloma associated with foreign body in immunocompetent patient without underlying lung disease. Tuberc Respir Dis (Seoul). 2013;74:231–4.CrossRef

Chien WL, Tseng JS. Pulmonary aspergillosis in an immunocompetent patient. Braz J Infect Dis. 2013;17:375–6.PubMedCrossRef

10.

Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac Imaging. 1992;7:56–74.PubMedCrossRef

11.

Zmeili OS, Soubani AO. Pulmonary aspergillosis: a clinical update. QJM. 2007;100:317–34.PubMedCrossRef

12.

Kang EY, Kim DH, Woo OH, et al. Pulmonary aspergillosis in immunocompetent hosts without underlying lesions of the lung: radiologic and pathologic findings. Am J Roentgenol. 2002;178:1395–9.CrossRef

13.

Yoon SH, Park CM, Goo JM, Lee HJ. Pulmonary aspergillosis in immunocompetent patients without air-meniscus sign and underlying lung disease: CT findings and histopathologic features. Acta Radiol. 2011;52:756–61.PubMedCrossRef

14.

Yoshida K, Kurashima A, Kamei K, Oritsu M, Ando T, Yamamoto T, Niki Y. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study. J Infect Chemother. 2012;18:378–85.PubMedCrossRef

15.

Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121:1988–99.PubMedCrossRef

Title: Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient: report of a rare case
Authors: E. Jin
L. M. Wang
Q. Y. Li
X. Feng
S. L. Ma
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 3/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-013-0575-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient: report of a rare case

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia

IGRA-positive patients and interferon-gamma/interleukin-2 signatures: Can the Fluorospot assay provide further information?

Are chlorhexidine-containing dressings safe for use with ventricular drainages?

Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients

Pulmonary toxocariasis: a case report and literature review

A rare case of Streptococcus agalactiae mycotic aneurysm and review of the literature

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page